This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Sir.—In their article "Newborn Thyroid Screening in a Municipal Hospital" (Journal 1982;136:248-250), Harris and Dreyfus pointed out the following problems that arise from the process of recall of newborns with abnormal screening results: the cost of recall of patients in the overall program, the anxiety for individual families, and the success rate in recall of patients requiring a second test. We would like to comment on some of these points in terms of our experience with neonatal screening for hypothyroidism.
First, in France, the state-mandated screening program for hypothyroidism and for phenylketonuria (PKU) is carried out in 21 area centers, geographically determined under the auspices of a national authority. All of these centers perform thyroid-stimulating hormone (TSH) determinations from dried blood spots. The cutoff value has been fixed to 30 μU/mL of blood.
Second, our center is one of these "regional centers" and screens 80,000 infants per year for
FARRIAUX JP, DHONDT JL. Newborn Thyroid Screening. Am J Dis Child. 1982;136(11):1030. doi:10.1001/archpedi.1982.03970470074025
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: